Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 15;17(12):e0278838. doi: 10.1371/journal.pone.0278838

Iron deficiency, anemia and association with refugee camp exposure among recently resettled refugees: A Canadian retrospective cohort study

Marta B Davidson 1,¤,*, Garielle Brown 2,3, Lesley Street 1, Kerry McBrien 2,4, Eric Norrie 2,3, Andrea Hull 3,4, Rachel Talavlikar 3,4, Linda Holdbrook 2, Gabriel E Fabreau 2,3,5
Editor: Mabel Aoun6
PMCID: PMC9754286  PMID: 36520858

Abstract

Malnutrition and poor health are common among recently resettled refugees and may be differentially associated with pre-migration exposure to refugee camp versus non-camp dwelling. We aimed to investigate the associations of iron deficiency (ID), anemia, and ID anemia (IDA) with pre-migration refugee camp exposure among recently arrived refugees to Canada. To this end, we conducted a retrospective cohort study of 1032 adult refugees who received care between January 1, 2011, and December 31, 2015, within a specialized refugee health clinic in Calgary, Canada. We evaluated the prevalence, severity, and predictors of ID, anemia, and IDA, stratified by sex. Using multivariable logistic regression, we estimated the association of refugee camp exposure with these outcomes, adjusting for age, months in Canada prior to investigations, global region of origin, and parity. Among female refugees, the prevalence of ID, anemia, and IDA was 25% (134/534), 21% (110/534), and 14% (76/534), respectively; among males, 0.8% (4/494), 1.8% (9/494), and 0% (0/494), respectively. Anemia was mild, moderate, and severe in 55% (60/110), 44% (48/110) and 1.8% (2/110) of anemic females. Refugee camp exposure was not associated with ID, anemia, or IDA while age by year (ID OR = 0.96, 95% CI 0.93–0.98; anemia OR = 0.98, 95% CI 0.96–1.00; IDA OR = 0.96, 95% CI 0.94–0.99) and months in Canada prior to investigations (ID OR = 0.85, 95% CI 0.72–1.01; anemia OR = 0.81, 95% CI 0.67–0.97; IDA OR = 0.80, 95% CI 0.64–1.00) were inversely correlated with these outcomes. ID, anemia, and IDA are common among recently arrived refugee women irrespective of refugee camp exposure. Our findings suggest these outcomes likely improve after resettlement; however, given proportionally few refugees are resettled globally, likely millions of refugee women and girls are affected.

Introduction

The world is facing an unprecedented global refugee crisis with an estimated 89.3 million people forcibly displaced from their homes and 27.1 million global refugees [1]. Refugees endure food and housing insecurity, limited healthcare access, and traumatic experiences that negatively impact their health status [2]. Currently, approximately 24% of the world’s refugees reside in camps, and the remaining majority live in urban and rural regions within host-nations [35]. Further, high burdens of malnutrition and poor health are common among refugee camp inhabitants [68]. The United Nations High Commission for Refugees (UNHCR) now aims to limit camp deployment, instead encouraging integrating refugees within urban host-nation communities whenever possible [3]. It is unclear how these policy changes may affect the nutrition and health of refugees.

Worldwide, iron deficiency (ID) is the most common nutritional deficiency, and anemia is its most commonly associated adverse health outcome [914]. ID and iron deficiency anemia (IDA) are most commonly caused by inadequate access to iron-rich foods or poor iron absorption [15]. In women and adolescent girls, ID is also linked to menstrual blood loss and high parity [16]. Further, enteric pathogens from exposures to contaminated drinking water or foods can cause chronic intestinal blood loss leading to ID [17]. Globally, anemia has been linked to poor pregnancy outcomes [18, 19], reduced work productivity [20, 21], increased morbidity and increased all-cause mortality [22]. Refugees residing in refugee camps experience high prevalence of anemia and nutritional deficiencies [23], especially among women and children [10, 2428]. It is currently unclear, however, if refugees in non-camp settings experience similar rates of nutritional deficiencies and anemia.

We aimed to characterize the prevalence and severity of ID, anemia, and IDA among recently-arrived adult refugees and claimants with and without pre-migration refugee camp exposure, and its differential association with these outcomes. We hypothesized that recently resettled refugees and asylum claimants exposed to refugee camps have higher prevalence and severity of ID, anemia, and IDA due to increased nutritional deficiencies compared to refugees living outside of refugee camps. Finally, we also aimed to characterize anemia unrelated to ID in this population.

Methods

Setting and data sources

We performed a retrospective cohort study among recently arrived refugees who presented to the Mosaic Refugee Health Clinic (MRHC) in Calgary, Canada. The MRHC is the only specialized refugee health clinic in its geographic area and provides multidisciplinary primary and specialty care to refugees and asylum claimants (claimants) for up to two years after resettlement. We performed a comprehensive chart review of electronic medical records (EMRs) using combined manual and automated methods to collect detailed sociodemographic, resettlement, clinical, biometric, laboratory, and clinic utilization data.

Study population

We included all refugees and claimants, herein referred to collectively as “refugees”, presenting to MRHC between January 1, 2011 and December 31, 2015 who: (1) were at least 18 years old at clinic intake, (2) had at least 2 clinic appointments, and (3) completed relevant laboratory investigations within 180 days of arrival to Canada, to investigate the associations of pre-migration refugee camp exposure with nutritional status and our outcomes of interest. We excluded subjects missing important data.

Study variables

In Canada, convention refugees are defined as “a person who meets the refugee definition in the 1951 Geneva Convention relating to the Status of refugees [29], and are classified as either government assisted refugees (GAR) or privately sponsored refugees (PSR) [30]. We defined claimants as either subjects that were seeking protection in Canada but had not yet received convention refugee status, or those who had their refugee claims rejected during the study period. We extracted sociodemographic data including sex, date of birth, country of origin, refugee category, and date of arrival to Canada from EMR-recorded immigration documents. We categorized country of origin according to the United Nations’ Geoscheme [31], and defined it as either a subject’s country of birth, citizenship or inhabitation prior to migration, depending on where they lived the longest. We considered refugee camp exposure present if it was recorded in the intake history, regardless of duration. Two chart abstractors followed a standardized protocol to manually abstracted each study subject’s clinical information from the EMR and categorize clinical diagnoses into ICD-10 codes [32]. Agreement between chart abstractors was >90% for clinical diagnostic codes; disagreements were resolved by a senior clinician. Among female subjects, pregnancy status and number of live children were recorded at intake. We considered subjects pregnant if pregnancy was confirmed at the time of laboratory investigations and assumed parity to be zero if it was not explicitly recorded in the EMR.

Study outcomes

We analyzed laboratory data to identify our primary outcomes of interest: ID, anemia, and IDA. Anemia was defined according to World Health Organization (WHO) definitions as: a hemoglobin <120g/L for all non-pregnant females ≥15 years of age, <110g/L for pregnant females ≥15 years of age, and <130g/L for males ≥15 years of age [33]. Among anemic refugees, we assessed anemia severity and morphology. We defined mild, moderate, and severe anemia among non-pregnant women as a hemoglobin concentration of: 110-119g/L, 80-109g/L, and <80g/L, respectively, and among pregnant women as 100-109g/L, 70-99g/L, and <70g/L, respectively [33]. In adult males ≥18 years of age, we defined mild, moderate, and severe anemia as a hemoglobin concentration of 110-129g/L, 80-109g/L, and <80g/L, respectively [33]. For all subjects we further classified anemia as: microcytic (<77 femtolitres [fl]), normocytic (77–96fl), or macrocytic (>96fl) [34]. Finally, we defined iron deficiency (ID) according to WHO standards as a serum ferritin concentration of <15μg/L [35, 36] and IDA as the concomitant presence of anemia and ID as outlined above.

Missing data

Fifty-six individuals were missing data for “number of children”, which was replaced with the most frequent and median number of children: two. We tested this assumption by replacing these 56 missing data points with zero, which did not change any study outcomes.

Statistical analysis

We stratified our analysis by sex given the known variation in prevalence of iron deficiency and anemia with sex [24]. We reported descriptive statistics according to refugee camp exposure, stratified by sex. We reported normally-distributed continuous variables as means with standard deviations (SD), and all non-normally distributed variables as medians with interquartile ranges [IQR]. We assessed statistical differences among demographic factors by refugee camp exposure using the Wilcoxon rank sum tests for non-normally-distributed variables, and the chi-square or Fisher’s exact tests for normally distributed variables.

We used univariate logistic regression models to estimate unadjusted odds ratios for the outcomes of interest, comparing refugees with and without camp exposure. Given the very low prevalence of anemia among males, we restricted our adjusted analyses to women only.

We initially utilized multivariable, two-level, logistic regression models with a random effect for UN region of origin, to account for non-random clustering of patients according to global regions and their associations with our outcomes of interest [19]. We allowed the UN region intercepts to vary randomly among patients (level 1) within similar UN global regions of origin (level 2). We then investigated the degree of patient clustering within global regions and sub-regions and its association with the variances observed for our outcomes of interest. The intraclass correlation coefficients was 0.001 for all three outcomes, indicating a negligible degree of clustering within global regions and sub-regions thus negating the need for multi-level regression models. We thus used multivariable logistic regression models to estimate the adjusted odds for the outcomes of interest among female refugees adjusting for refugee camp exposure, age, UN global region of origin (Africa as reference group), number of months in Canada prior to laboratory investigations, active pregnancy status (for ID), and number of children (parity).

Sensitivity analysis

To test our definition of ID based on serum ferritin concentration, we performed a sensitivity analysis whereby we assessed our outcomes of interest using ID defined as a transferrin saturation (tsat) of less than 0.16 [33] and IDA as anemia with a concomitant tsat <0.16.

Exploratory analysis

For all anemia cases not associated with ID (ferritin <15g/L), we explored patient records for alternate etiologies of anemia and characterized these conditions by ICD-10 diagnostic codes. We then classified these conditions into the following categories: B12 deficiency, thalassemic conditions, ID, and other if patients did not have any anemia-specific ICD-10 codes documented within 6 months of arrival to Canada. ID or IDA diagnoses were excluded if the patient’s ferritin concentration was above 100g/L, a level largely considered adequate to rule out ID even in context of inflammatory states [37]. In these cases, we sought other anemia-diagnoses from patients’ charts.

All analyses were performed using Stata 14 (College Station, TX USA: StataCorp LLC) and SAS 9.4 (Cary, NC, USA: SAS Institute Inc.) and considered a 2-tailed alpha <0.05 as statistically significant. This study was approved by the University of Calgary Research Ethics Board.

Results

Baseline characteristics

We identified 1032 adult refugee patients in our cohort, with 52% (534/1032) females and 48% (498/1032) males (Fig 1). The median age was 32.6 years [26.3–41.3] and 31.2 years [25.2–39.8] among males and females, respectively. Subjects originated from 47 different countries. The top five countries of origin were Eritrea (23%), Iraq (14%), Ethiopia (13%), Afghanistan (6%) and Bhutan (6%). Among UN global regions, 53% (542/1032) of refugee patients were from Africa, 45% (461/1032) were from Asia, 2% (22/1032) were from the Americas, and 1% (10/1032) were from Europe (Table 1). Overall, 18.7% (193/1032) of refugees were exposed to a refugee camp, with African and government assisted refugees (GAR) overrepresented among those exposed. Among females, English proficiency varied by refugee camp exposure, but pregnancy rates and number of children did not (Table 1).

Fig 1. Flow chart of study.

Fig 1

See text for details.

Table 1. Patient characteristics by sex and refugee camp exposure (N = 1032).

Variable Female N = 534 Male N = 498
Refugee Camp + Refugee Camp - p-value* Refugee Camp + Refugee Camp - p-value*
N = 94 N = 440 N = 99 N = 399
Age (years)–Median [IQR] 30.3 [23.6–38.3] 31.4 [25.5–40.0] 0.28 32.0 [25.5–42.4] 32.7 [26.5–41.1] 0.92
Months in Canada Prior to Blood Tests–Median [IQR] 1.1 [0.7–1.9] 1.4 [0.8–2.5] 0.08 1.2 [0.8–2.1] 1.3 [0.7–2.6] 0.69
UN Global Region–N (%)
 Africa 63 (67.0) 206 (46.8) < 0.01 69 (69.7) 204 (51.1) < 0.01
 Americas 0 (0) 17 (3.9) 0 (0) 5 (1.3)
 Asia 31 (33) 210 (47.7) 30 (30.3) 190 (47.6)
 Europe 0 (0) 7 (1.6) 0 (0) 0 (0)
Number of Children–Median [IQR] 1 [0–4] 2 [0–3] 0.43 1 [0–2] 1 [0–2] 0.86
Pregnancy^–N (%)
 Yes 6 (6.4) 48 (10.9) 0.19 N/A
 No 88 (93.6) 392 (89.1)
Refugee Category #
 GAR 71 (75.5) 204 (46.4) < 0.01 65 (65.7) 188 (47.1) < 0.01
 PSR 23 (24.5) 191 (43.4) 34 (34.3) 180 (45.1)
 Claimant 0 (0) 45 (10.2) 0 (0) 31 (7.8)
English Language proficiency at intake–N (%)
 None 61 (64.9) 214 (48.6) 38 (38.4) 129 (32.3)
 Limited 11 (11.7) 73 (16.6) 20 (20.2) 86 (21.6)
 Good 22 (23.4) 153 (34.8) 0.02 41 (41.4) 184 (46.1) 0.52

*p-values calculated using a Wilcoxon rank sum test for comparison of medians and chi-square or Fisher’s exact tests for comparison of frequencies.

#GAR refer to Government assisted refugees, PSR refers to privately sponsored refugees, and Claimant refers to refugee claimants or asylum seeker.

^Pregnant refers to active pregnancy at the time of laboratory investigations. N/A refers to not applicable.

Prevalence of ID, anemia, and IDA among refugees

Among all subjects, the median time from arrival to Canada to first laboratory investigations was 39 days [22–72 days]. Among females and males, the prevalence of ID was 25% (134/534) and 0.8% (4/498), respectively (p<0.01) (Fig 2A), the median ferritin level was 29μg/L [14–57μg/L] and 120.5μg/L [70–186μg/L] (p<0.01), respectively, and the prevalence of anemia was 21% (110/534) and 1.8% (9/498), respectively (p<0.01). Sixty-nine percent (76/110) of anemia among females was attributed to ID. There were no IDA cases among males. Among anemic females, 55% (60/110) had mild, 44% (48/110) had moderate, and 2% (2/110) had severe anemia. Among anemic males, 78% (7/9) had mild, 22% (2/9) had moderate, and none had severe anemia (Fig 2B). Among anemic subjects, most anemia was normocytic and only one female had macrocytic anemia (Fig 2C).

Fig 2. Iron deficiency and anemia characteristics in adult refugees resettled to Calgary, Alberta.

Fig 2

(A) Prevalence of ID, anemia, and IDA in male and female refugees. We defined ID as a serum ferritin <15μg/L and anemia according to the WHO standards [15]. (B) Anemia severity in male and female refugees. Among non-pregnant women we defined mild, moderate, and severe anemia as a hemoglobin concentration of 110-119g/L, 80-109g/L, and below 80g/L, respectively, and 100-109g/L, 70-99g/L, and <70g/L, respectively among pregnant women. In adult males ≥18 years of age, we defined mild, moderate, and severe anemia as hemoglobin concentrations of 110-129g/L, 80-109g/L, and <80g/L respectively. (C) Anemia morphology. Anemia was classified as microcytic (<77fl), normocytic (77–96fl), or macrocytic (>96fl).

Unadjusted outcomes

Table 2 summarizes the prevalence of ID, anemia, and IDA among all subjects by refugee camp exposure stratified by sex. There were no prevalence differences in the outcomes of interest by refugee camp exposure. In our unadjusted analysis restricted to females (Table 3), refugee camp exposure, UN region of origin, and number of children were not associated with any of the outcomes of interest; however, each increased year of age and each month in Canada prior to laboratory investigations were inversely associated with these outcomes. Pregnancy was associated with ID but was not tested against anemia or IDA as we used pregnancy specific definitions for these outcomes (Table 3).

Table 2. Primary outcomes by sex and refugee camp exposure (N = 1032).
Variable Female N = 534 Male N = 498
Refugee Camp + Refugee Camp - p-value* Refugee Camp + Refugee Camp - p-value*
N = 94 N = 440 N = 99 N = 399
Iron Deficiency–N (%) 19 (20.2) 115 (26.1) 0.24 0 (0) 4 (1.0) 0.99
Anemia–N (%) 19 (20.2) 91 (20.7) 0.99 4 (4.0) 5 (1.3) 0.08
Iron Deficiency Anemia–N (%) 12 (12.8) 64 (14.6) 0.75 0 (0) 0 (0)
Table 3. Unadjusted outcomes for females (N = 534).
Variables Iron Deficiency Anemia Iron Deficiency Anemia
Unadjusted Odds Ratio [95% CI] Unadjusted Odds Ratio [95% CI] Unadjusted Odds Ratio [95% CI]
Refugee Camp Exposure 0.72 [0.41–1.24] 0.97 [0.56–1.69] 0.86 [0.44–1.67]
Age (in years) at First Appointment 0.97 [0.95–0.99] 0.98 [0.96–1.00]* 0.96 [0.94–0.99]
Months in Canada Prior to Blood Tests 0.83 [0.71–0.97] 0.83 [0.70–0.99] 0.82 [0.66–1.00]**
UN Global Region Calculated vs. Africa Calculated vs. Africa Calculated vs. Africa
 Americas 0.75 [0.21–2.68] 0.47 [0.11–2.13] 0.38 [0.05–2.95]
 Asia 1.37 [0.92–2.05] 0.86 [0.56–1.33] 1.03 [0.63–1.70]
 Europe 2.61 [0.57–12.00] 1.42 [0.27–7.53] 2.43 [0.46–12.99]
Number of Children 0.99 [0.90–1.10] 0.93 [0.83–1.04] 0.91 [0.79–1.04]
Pregnant ^ 1.89 [1.05–3.41] N/A N/A

*Results statistically significant, p = 0.012.

**Results statistically significant, p = 0.04.

^Pregnant refers to active pregnancy at the time laboratory investigations were drawn.

Adjusted analysis

In our adjusted analysis, refugee camp exposure was not associated with our outcomes of interest among female refugees (Fig 3). Further, UN region of origin, pregnancy, and number of children were also not associated with ID, anemia, or IDA. Each increased year of age at first clinic appointment was associated with 4% and 3% decreased odds of ID and IDA, respectively (Fig 3). Finally, each month in Canada prior to when laboratory investigations were drawn was associated with 19% and 20% decreased odds of anemia and IDA, respectively (Fig 3).

Fig 3. Predictors of ID, Anemia, and IDA in recently resettled global female refugees.

Fig 3

Multi-variable logistic regression was used to estimate the odds of ID, anemia, and IDA in female refugees after adjusting for refugee camp exposure, age, global region of origin (defined by UN global regions), pregnancy status and number of children. (*) indicates p-value <0.05.

Sensitivity analysis

In our sensitivity analysis, the overall prevalence of ID obtained using transferrin saturation (tsat) [21.5% (222/1032)] was higher than using a ferritin-based definition [13.3% (138/1032)] (S1 Table). However, this did not change the results of our unadjusted (S2 Table) or adjusted analysis (S1 Fig).

Exploratory analysis: Determinants of non-iron deficiency associated anemia

Among anemia cases, 36% (43/119) were not attributable to ID as defined in our study. In these 43 non-ID subjects, physicians assigned diagnoses of IDA in 44% (19/43), thalassemia trait in 16% (7/43), and B12 deficiency in 5% (2/43) of individuals (Fig 4). Thirty-five percent (15/43) of these individuals did not have an explicit cause of anemia identified (Fig 4). Among patients with physician-assigned diagnoses of IDA, the median ferritin was 22.5μg/L [17–33μg/L]. Two patients were misclassified as having IDA by physician-assigned diagnoses as each had ferritin concentrations of >100μg/L; we therefore excluded these cases from median ferritin calculations. When we combined physician assigned cases of IDA with laboratory-defined cases, ID accounted for 80% (95/119) of anemia cases in our cohort.

Fig 4. Etiology of anemia not attributable to iron deficiency.

Fig 4

Conditions causing anemia using ICD10 diagnostic codes extracted from charts among patients with anemia, but a serum ferritin concentration >15μg/L (N = 43).

Discussion

Among a global cohort of adult refugees recently arrived in Canada, iron deficiency (ID), anemia, and iron deficiency anemia (IDA) were highly prevalent conditions irrespective of pre-migration refugee camp exposure. This was especially notable among female refugees, in whom the prevalence of ID was almost three times higher than that reported for adult Canadian females [38]. Contrary to our hypothesis, ID, anemia, and IDA were not associated with previous refugee camp exposure. However, we found that 82% of anemia cases among adult refugees were attributable to nutritional deficiencies (Iron or B12), and that inherited red blood cell disorders or other causes of anemia were rare. Given that refugees in our cohort completed laboratory investigations with a median time of 39 days after arrival to Canada, our findings likely reflect pre-migration hematologic indices, as well as nutritional and health status.

The 21% anemia prevalence among refugee women in our study is consistent with previous reports [10, 25, 26, 39], and indicates a condition of moderate public health significance by WHO criteria [15]. We found female refugees had a 31-fold higher prevalence of ID and an 11-fold higher prevalence of anemia compared to males [24], consistent with higher anemia frequencies among women reported globally [10, 25, 26, 39]. We found that 25% of refugee women were iron deficient, which is likely an underestimate as we used a stringent ferritin concentration threshold of 15μg/L to define ID that likely misses milder, but clinically relevant deficiencies [40, 41]. Using our stringent ID definition, we found that almost 70% of anemic females had laboratory confirmed ID. Moreover, when we included physician assigned IDA cases with a median ferritin concentration of 22.5μg/L, ID accounted for 84% of observed anemia among women. This further suggests that our estimates are conservative, and that refugee women are at high risk for ID and anemia and their associated adverse health outcomes, irrespective of refugee camp exposure or global region or origin.

To our knowledge, this is the first study to investigate the association of nutritional and health status with pre-migration refugee camp exposure among global refugees, from 47 different countries, resettled to a high-income country. Overall, we found no differences in the prevalence of ID, anemia, and IDA among refugees by refugee camp exposure. Our findings suggest that refugees in non-camp settings (often in urban settings) may experience similar nutritional deficiencies as well as barriers accessing food and nutritional supports as camp-dwelling refugees. A recent systematic review also showed that nutritional deficiencies are a significant problem among non-camp dwelling refugees [42]. A number of factors may be contributing to this problem. For example, non-camp refugees may lack access to supports from the World Food Programme [43] and other international aid organizations that traditionally support refugees in camp settings. Further, the majority of displaced persons are relocated to lower income countries [1, 42], which likely have limited resources to offer to urban-dwelling refugees. Our findings appear to contradict the purported health and economic benefits of non-camp dwelling for refugees cited by the UNHCR such as greater freedom of movement and access to employment, given that nutritional deficiencies and food access barriers are most often related to poverty [3].

While high rates of ID and anemia have been documented in selected refugee camps [23], refugee camp exposure has been variably associated with anemia in the literature. For example, among pregnant Sudanese refugees in Ethiopia, anemia was inversely associated with duration of residence in a refugee camp [44]. By contrast, Syrian refugee women in refugee camps in Jordan, but not in Lebanon, were more likely to be anemic than their non-camp counterparts [6, 45]. In Southeast Asia, among refugees from Vietnam, Laos, and Cambodia, there was no association between anemia and refugee camp residence after accounting for ethnicity [19]. These observed differences may be due to the geographic and cultural variability between different refugee camps, as well as significant differences in their availability of nutrition supports and medical services. Unlike previous studies that have been limited to specific global sub-regions and individual ethnocultural populations, our study investigated a global cohort of refugees across 47 countries of origin. We found negligible clustering by UN global region of origin for ID, anemia, and IDA, suggesting that the associations of interest were not significantly different across global regions. Together our findings suggest that ID, often related to food insecurity, is highly prevalent in pre-menopausal refugee women irrespective of pre-migration living situation or global origin.

Our study has limitations that warrant consideration. As our study was conducted at a single site, it may not be representative of refugee populations in other host-regions. Further, our study enrolment ended prior to the influx of approximately 41,000 Syrian refugees to Canada in 2015–2016, and more recent Afghan and Ukrainian refugees [46, 47], thus, it may not represent the current global refugee population. While our study is amongst the largest Canadian refugee cohort studies conducted to-date and comprised a heterogeneous global refugee cohort from 47 different countries, it is underpowered to assess country-specific variations which may factor into the lack of significant regional or sub-regional variation in our outcomes. Moreover, we only identified two cases of severe anemia in our study and may underestimate the prevalence of severe anemia cases that may present to acute care settings. This may be due to a selection bias given that our study relied on outpatient laboratory tests. Alternatively, selection pressures during the refugee migration process may select against individuals with severe anemia who may succumb to its complications or be unable to travel [48]. In addition, because our study was restricted to adult refugees and claimants, post-menarche adolescent girls, who likely also experience high prevalence of ID, anemia, and IDA were not included, thus potentially underestimating their prevalence. Finally, in our cohort, 19% of refugees had resided in a refugee camp prior to arrival in Canada, lower than current global trends, where 24% of global refugees reside in camps [4], suggesting camp-exposure may be underrepresented in our cohort.

Taken together, our findings, in concordance with other global data, suggest that refugee women commonly experience ID and IDA, and that refugee status itself, irrespective of pre-migration dwelling, region of origin, or political refugee class predicts these nutritional deficiency-related conditions. Our findings support the current Canadian Collaboration for Immigrant and Refugee Health (CCIRH) screening guidelines, which recommend screening all female refugees, but not males for anemia and ID [49]. In our cohort, anemia varied inversely with months spent in Canada prior to laboratory investigations, suggesting that it may be largely remediable in food-secure environments and with access to high quality primary healthcare.

The unprecedented number of forcibly displaced people globally highlights the scale of the population at risk for nutritional deficiencies. Further, the magnitude of the burden of ID and IDA among displaced women and adolescent females likely reaches at least a moderate public health concern by WHO criteria and warrants consideration of large-scale action to prevent adverse outcomes of this readily preventable nutritional deficiency. Globally, less than 2% of refugees are resettled in high income countries such as Canada; however, studies among multinational cohorts of recently resettled refugees can improve understanding of health conditions faced by refugees regionally and universally [50]. Future studies of ID and anemia among global refugees would help to elucidate if regional and cultural differences exist, and if their prevalence varies across different nutritional and medical assistance models between refugee camps. Improved understanding of nutritional deficiencies in refugee populations may inform treatment and prevention programs, such as targeted iron supplementation programs for pre-menopausal refugee women and adolescent girls.

Supporting information

S1 Fig. Sensitivity analysis.

For sensitivity analysis, ID was defined as a serum transferrin saturation (tsat) ≤ 0.16 and IDA was defined as the presence of anemia as defined by WHO thresholds in combination with a tsat ≤ 0.16. Multi-variable logistic regression was used to estimate the odds of ID, anemia, and IDA in female refugees after adjusting for refugee camp exposure, age, global region of origin (defined by UN global regions), pregnancy status and number of children.

(TIF)

S1 Table. Sensitivity analysis; primary outcomes by sex and refugee camp exposure using serum transferrin saturation (tsat) (N = 1032).

(DOCX)

S2 Table. Sensitivity analysis: Unadjusted outcomes among female refugees using transferring saturation (tsat) (N = 534).

(DOCX)

Acknowledgments

We would like to thank the healthcare providers, staff and patients at the Mosaic Refugee Health Clinic the institutional support provided by, the O’Brien Institute for Public Health, the Department of Medicine and the W21C Research and Innovation Centre at the University of Calgary Cumming School of Medicine.

Data Availability

Data cannot be shared publicly because permission is restricted by the data custodian and current active research agreement. For further inquiries regarding the data sharing restrictions please contact the data custodian’s (the Mosaic Primary Care Network) privacy officer Dr. Valerie Fleisch (privacy@mosaicpcn.ca).

Funding Statement

GEF received research grant support from the MSI Foundation, the O’Brien Institute for Public Health and Department of Medicine at the University of Calgary for the submitted work

References

  • 1.UNHCR. Global Trends Report: Forced Displacement in 2021: The UN Refugee Agency; 2022 [cited 2022. Available from: https://www.unhcr.org/62a9d1494/global-trends-report-2021].
  • 2.Schilling T, Rauscher S, Menzel C, Reichenauer S, Muller-Schilling M, Schmid S, et al. Migrants and Refugees in Europe: Challenges, Experiences and Contributions. Visc Med. 2017;33(4):295–300. doi: 10.1159/000478763 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.UNHCR. Alternatives To Camps 2014 [Available from: http://www.unhcr.org/protection/statelessness/5422b8f09/unhcr-policy-alternatives-camps.html].
  • 4.UNHCR. Diagnostic Tool for Alternatives to Camps 2017 Global Results 2017.
  • 5.UNHCR. Shelter: The UN Refugee Agency; 2022 [Available from: https://www.unhcr.org/shelter.html].
  • 6.Bilukha OO, Jayasekaran D, Burton A, Faender G, King’ori J, Amiri M, et al. Nutritional status of women and child refugees from Syria-Jordan, April-May 2014. MMWR Morb Mortal Wkly Rep. 2014;63(29):638–9. [PMC free article] [PubMed] [Google Scholar]
  • 7.Lutfy C, Cookson ST, Talley L, Rochat R. Malnourished children in refugee camps and lack of connection with services after US resettlement. J Immigr Minor Health. 2014;16(5):1016–22. doi: 10.1007/s10903-013-9796-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Seal AJ, Creeke PI, Mirghani Z, Abdalla F, McBurney RP, Pratt LS, et al. Iron and vitamin A deficiency in long-term African refugees. J Nutr. 2005;135(4):808–13. doi: 10.1093/jn/135.4.808 [DOI] [PubMed] [Google Scholar]
  • 9.Redditt VJ, Janakiram P, Graziano D, Rashid M. Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases. Can Fam Physician. 2015;61(7):e303–9. [PMC free article] [PubMed] [Google Scholar]
  • 10.Redditt VJ, Graziano D, Janakiram P, Rashid M. Health status of newly arrived refugees in Toronto, Ont: Part 2: chronic diseases. Can Fam Physician. 2015;61(7):e310–5. [PMC free article] [PubMed] [Google Scholar]
  • 11.Tiong AC, Patel MS, Gardiner J, Ryan R, Linton KS, Walker KA, et al. Health issues in newly arrived African refugees attending general practice clinics in Melbourne. Med J Aust. 2006;185(11–12):602–6. doi: 10.5694/j.1326-5377.2006.tb00724.x [DOI] [PubMed] [Google Scholar]
  • 12.Stellinga-Boelen AA, Storm H, Wiegersma PA, Bijleveld CM, Verkade HJ. Iron deficiency among children of asylum seekers in the Netherlands. J Pediatr Gastroenterol Nutr. 2007;45(5):591–5. doi: 10.1097/MPG.0b013e31810e76a5 [DOI] [PubMed] [Google Scholar]
  • 13.Salehi L, Lofters AK, Hoffmann SM, Polsky JY, Rouleau KD. Health and growth status of immigrant and refugee children in Toronto, Ontario: A retrospective chart review. Paediatr Child Health. 2015;20(8):e38–42. doi: 10.1093/pch/20.8.e38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Paxton GA, Sangster KJ, Maxwell EL, McBride CR, Drewe RH. Post-arrival health screening in Karen refugees in Australia. PLoS One. 2012;7(5):e38194. doi: 10.1371/journal.pone.0038194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.De Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. 2008. Geneva: World Health Organization Google Scholar. 2011.
  • 16.Breymann C, Auerbach M. Iron deficiency in gynecology and obstetrics: clinical implications and management. Hematology Am Soc Hematol Educ Program. 2017;2017(1):152–9. doi: 10.1182/asheducation-2017.1.152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tolentino K, Friedman JF. An update on anemia in less developed countries. Am J Trop Med Hyg. 2007;77(1):44–51. [PubMed] [Google Scholar]
  • 18.Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr. 1994;59(2 Suppl):492S-500S discussion S-1S. doi: 10.1093/ajcn/59.2.492S [DOI] [PubMed] [Google Scholar]
  • 19.Catanzaro A, Moser RJ. Health status of refugees from Vietnam, Laos, and Cambodia. JAMA. 1982;247(9):1303–8. [PubMed] [Google Scholar]
  • 20.Ohira Y, Edgerton VR, Gardner GW, Gunawardena KA, Senewiratne B, Ikawa S. Work capacity after iron treatment as a function of hemoglobin and iron deficiency. J Nutr Sci Vitaminol (Tokyo). 1981;27(2):87–96. doi: 10.3177/jnsv.27.87 [DOI] [PubMed] [Google Scholar]
  • 21.Edgerton VR, Ohira Y, Hettiarachchi J, Senewiratne B, Gardner GW, Barnard RJ. Elevation of hemoglobin and work tolerance in iron-deficient subjects. J Nutr Sci Vitaminol (Tokyo). 1981;27(2):77–86. doi: 10.3177/jnsv.27.77 [DOI] [PubMed] [Google Scholar]
  • 22.Martinsson A, Andersson C, Andell P, Koul S, Engstrom G, Smith JG. Anemia in the general population: prevalence, clinical correlates and prognostic impact. Eur J Epidemiol. 2014;29(7):489–98. doi: 10.1007/s10654-014-9929-9 [DOI] [PubMed] [Google Scholar]
  • 23.Refugees UNHCF. UNHCR Strategic Plan for Anaemia Prevention, Control and Reduction. Reducing the global burden of anaemia in refugee populations 2008–2010. 2010.
  • 24.Kassebaum NJ, Collaborators GBDA. The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016;30(2):247–308. doi: 10.1016/j.hoc.2015.11.002 [DOI] [PubMed] [Google Scholar]
  • 25.Johnston V, Smith L, Roydhouse H. The health of newly arrived refugees to the Top End of Australia: results of a clinical audit at the Darwin Refugee Health Service. Aust J Prim Health. 2012;18(3):242–7. doi: 10.1071/PY11065 [DOI] [PubMed] [Google Scholar]
  • 26.Ouimet MJ, Munoz M, Narasiah L, Rambure V, Correa JA. [Current pathologies among asylum seekers in Montreal: prevalence and associated risk factors]. Can J Public Health. 2008;99(6):499–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ahmed RH, Yussuf AA, Ali AA, Iyow SN, Abdulahi M, Mohamed LM, et al. Anemia among pregnant women in internally displaced camps in Mogadishu, Somalia: a cross-sectional study on prevalence, severity and associated risk factors. BMC Pregnancy Childbirth. 2021;21(1):832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Engidaw MT, Wassie MM, Teferra AS. Anemia and associated factors among adolescent girls living in Aw-Barre refugee camp, Somali regional state, Southeast Ethiopia. PLoS One. 2018;13(10):e0205381. doi: 10.1371/journal.pone.0205381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Refugees CCf. Refugees and Immigrants: A glossary [Available from: http://ccrweb.ca/en/glossary].
  • 30.Canada Go. Terms and definitions related to refugee protection. 2019 [Available from: https://www.canada.ca/en/immigration-refugees-citizenship/corporate/publications-manuals/operational-bulletins-manuals/refugee-protection/terms-definitions-related-refugee-protection.html].
  • 31.United Nations SD. 2018 [Available from: https://unstats.un.org/unsd/methodology/m49/].
  • 32.International Statistical Classification of Diseases and Related Health Problems 10th Revision [Available from: http://apps.who.int/classifications/icd10/browse/2010/en].
  • 33.Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. [Internet]. World Health Organization. 2011. Available from: https://www.who.int/vmnis/indicators/haemoglobin.pdf.
  • 34.Brugnara C, Mohandas N. Red cell indices in classification and treatment of anemias: from M.M. Wintrobes’s original 1934 classification to the third millennium. Curr Opin Hematol. 2013;20(3):222–30. doi: 10.1097/MOH.0b013e32835f5933 [DOI] [PubMed] [Google Scholar]
  • 35.Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7(2):145–53. doi: 10.1007/BF02598003 [DOI] [PubMed] [Google Scholar]
  • 36.Organization WH. Iron Deficiency Anaemia: Assessment, Prevention And Control. A guide for programme managers. WHO; 2001.
  • 37.Camaschella C. Iron-Deficiency Anemia. N Engl J Med. 2015;373(5):485–6. [DOI] [PubMed] [Google Scholar]
  • 38.Cooper M, Greene-Finestone L, Lowell H, Levesque J, Robinson S. Iron sufficiency of Canadians. Health Rep. 2012;23(4):41–8. [PubMed] [Google Scholar]
  • 39.Jablonka A, Wetzke M, Sogkas G, Dopfer C, Schmidt RE, Behrens GMN, et al. Prevalence and Types of Anemia in a Large Refugee Cohort in Western Europe in 2015. J Immigr Minor Health. 2018. [DOI] [PubMed] [Google Scholar]
  • 40.Ali MA, Luxton AW, Walker WH. Serum ferritin concentration and bone marrow iron stores: a prospective study. Can Med Assoc J. 1978;118(8):945–6. [PMC free article] [PubMed] [Google Scholar]
  • 41.Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161(5):639–48. doi: 10.1111/bjh.12311 [DOI] [PubMed] [Google Scholar]
  • 42.Khuri J, Wang Y, Holden K, Fly AD, Mbogori T, Mueller S, et al. Dietary Intake and Nutritional Status among Refugees in Host Countries: A Systematic Review. Adv Nutr. 2022;13(5):1846–65. doi: 10.1093/advances/nmac051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.UNHCR. World Food Programme: The UN Refugee Agency; 2022 [Available from: https://www.unhcr.org/world-food-programme-49eed2ba6.html].
  • 44.Alemayehu A, Gedefaw L, Yemane T, Asres Y. Prevalence, Severity, and Determinant Factors of Anemia among Pregnant Women in South Sudanese Refugees, Pugnido, Western Ethiopia. Anemia. 2016;2016:9817358. doi: 10.1155/2016/9817358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hossain SM, Leidman E, Kingori J, Al Harun A, Bilukha OO. Nutritional situation among Syrian refugees hosted in Iraq, Jordan, and Lebanon: cross sectional surveys. Confl Health. 2016;10:26. doi: 10.1186/s13031-016-0093-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Canada Go. #WelcomeAfghans: Key figures: Immigration, Refugees and Citizenship Canada; 2022 [Available from: https://www.canada.ca/en/immigration-refugees-citizenship/services/refugees/afghanistan/key-figures.html].
  • 47.Canada Go. Canada-Ukraine Authorization for Emergency Travel: Immigration, Refugees and Citizenship Canada; 2022 [Available from: https://www.canada.ca/en/immigration-refugees-citizenship/news/2022/03/canada-ukraine-authorization-for-emergency-travel.html].
  • 48.Abubakar I, Aldridge RW, Devakumar D, Orcutt M, Burns R, Barreto ML, et al. The UCL-Lancet Commission on Migration and Health: the health of a world on the move. Lancet. 2018;392(10164):2606–54. doi: 10.1016/S0140-6736(18)32114-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, et al. Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011;183(12):E824–925. doi: 10.1503/cmaj.090313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.UNHCR. Figures at a glance 2019 [Available from: http://www.unhcr.org/statistics].

Decision Letter 0

Sabeena Jalal

8 Jun 2021

PONE-D-21-12986

Iron deficiency, Anemia and Association with Refugee Camp Exposure Among Recently Resettled Refugees:  a Canadian retrospective cohort study

PLOS ONE

Dear Dr. Davidson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sabeena Jalal, MBBS, MSc, MSc, SM

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Additional Editor Comments (if provided):

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 15;17(12):e0278838. doi: 10.1371/journal.pone.0278838.r002

Author response to Decision Letter 0


20 Sep 2021

Dear Editor:

Thank you for taking the time to review our manuscript entitled “Iron deficiency, anemia and association with refugee camp exposure among recently resettled refugees: a Canadian retrospective cohort study”, and for your insightful suggestions on how to improve it.

We have addressed your requirements as follows:

1. “Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming”

• You will now find the manuscript is in compliance with PLOS One style requirements. A marked-up copy and a “clean” copy of the manuscript have been uploaded.

2. “Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly”

• Captions for Supporting Information files have now been included at the end of the manuscript and in-text citations have been updated accordingly.

3. “We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly.”

• While we agree that sharing open data would enhance confidence and accountability in research, our current data-sharing agreement with the data custodian (The Mosaic Primary Care Network) from whom our clinical data comes, does not allow any sharing of data with third parties, even fully de-identified data. Since these requested revisions, I have reviewed our agreements with their privacy officer and have tried to advocate for sharing with your journal, but this would require a fully executed revision to our existing legal agreement which would take many weeks between their organization and the University of Calgary. Unfortunately, we would not be able to pursue these amendments and provide revisions in a reasonable amount of time to the journal.

Despite this restriction, we have assembled and provided all our raw data output from our analyses, including the STATA code we developed to perform these analyses. We hope that providing our raw analyses will provide the reviewers confidence in our methodology and the results we present. We reviewed provision of these analyses and code with our research ethics board and data custodian, both of whom had no concerns with providing them for the journal.

For further inquiries regarding the data sharing restrictions please contact the data custodian’s privacy officer Dr. Valerie Fleisch (privacy@mosaicpcn.ca).

4. “Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.”

• The reference list has been reviewed and is complete and correct. There are no references to retracted articles.

We hope that you will find our revisions satisfactory.

Marta Davidson

Attachment

Submitted filename: Response to reviewers - Sept 17.21.docx

Decision Letter 1

Sabeena Jalal

31 Aug 2022

PONE-D-21-12986R1Iron deficiency, Anemia and Association with Refugee Camp Exposure Among Recently Resettled Refugees:  a Canadian retrospective cohort studyPLOS ONE

Dear Dr. Davidson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thank you for  submitting this manuscript, and the revisions.  Please replace the pie chart by a bar graph. Please elaborate the points raised by one of the reviewers in your limitations section. Thank you.

==============================

Please submit your revised manuscript by Oct 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sabeena Jalal, MBBS, MSc, MSc, SM

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Important research work. I had reviewed a revision. Authors did a good job of incorporating the required changes.

Reviewer #2: This study’s purpose was to determine the identify a disparity in iron deficiency (ID), anemia, and iron deficiency anemia (IDA) in refugees depending on whether they had stayed in a refugee camp prior to coming to Canada. The study explains that refugee camps, oftentimes, lead to poor health outcomes and so suggested that there would be a higher prevalence of these disease among refugees who have experience such camps. However, the study finds that there is no association between refugee camp exposure and ID, anemia, or IDA. The study does conclude a relationship between ID, anemia, and IDA between gender with women had significantly more cases as well as an inverse correlation with age and months before arriving to Canada. The study does a great job of contextualizing the study in the setting of refugee camps and makes a logical relationship of refugee camps to ID, anemia, and IDA. This logical relationship builds a strong argument as to why such diseases should be studied and how refugee camps can influence the prevalence of these disease. Another strength of the paper is the logical data analysis as the study manages to use the correct statistical analyses while also highlighting the biases that may be present in the data, such as the difference in cutoff for iron deficiency depending on the statistic used. Some weaknesses of the paper relate to the study ignoring certain confounding variables such as culture with sufficient depth as well as formatting issues with regards to data presentation.

The study displays major issues with argument flow in the conclusion as well as not considering certain confounding variables. The study mentions that culture is a significant factor in disease prevalence among different ethnic groups of refugees. However, the study does not consider culture during their data analysis and does not account for biases towards certain ethnic cultures over others when investigating the impact of refugee camps. An attempt to consider culture is made on lines 184-193 but while stating the proportion of cultures is a good start, these proportions are not accounted for data analysis.

Another major issue is related to the conclusion of whether refugee camps play a role in ID, anemia, and IDA prevalence. The study concludes that it does not but does not offer any reasons as to why this may be the case. This lack of support makes the conclusion lose validity. Furthermore, the study uses its conclusions to further explain society consequences of the refugees in lines 303-305 but this extension does not seem appropriate before validating the conclusions of this study.

The limitations section of the study provides number limitations but without explanation. Explanations are important because it allows the reader to understand how the limitations may have impacted the data collection and data processing.

There were also some formatting issues in the report for data tables. Table 1 was difficult to read in some areas due to units not being clear for certain rows such as the numbers in brackets corresponding to the row “Months in Canada Prior to Blood.”

Another issue is with result presentation. A pie chart is oftentimes not suitable to display proportions exceeding two variables because the proportions become difficult to compare. Therefore, I would recommend changing the graph type to a more suitable graph where the comparisons between variables are more obvious, such as a bar graph.

Lastly, there are grammatical issues in the report. An example is the limitations paragraph which starts with a four-word topic sentence and does not adequately explain what the paragraph will be about. Furthermore, there is no flow in this paragraph as each idea is brought forward without explanation and separated by periods. There are examples of awkward syntax such as the sentence on lines 139-141 having no verb and therefore, not being a complete sentence.

Overall, the study does a great job of giving a holistic overview of ID, anemia, IDA among refugees by giving a strong foundation for the reader and also an in-depth statistical analysis of the data to come to a conclusion. However, the report has problems in addressing certain biases as well as present evidence for specific conclusions.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 15;17(12):e0278838. doi: 10.1371/journal.pone.0278838.r004

Author response to Decision Letter 1


15 Oct 2022

Marta Davidson, PhD MD FRCPC

Hematologist

Division of Medical Oncology and Hematology

Princess Margaret Cancer Center

700 University Ave, 6W091

Toronto, Ontario M5G 1Z5

October 15, 2022

To the Editor and Reviewers:

We thank you for taking the time to to review our manuscript entitled “Iron deficiency, anemia and association with refugee camp exposure among recently resettled refugees: a Canadian retrospective cohort study”, and for your insightful suggestions on how to improve it. We have addressed each comment individually below. We trust that you will find our revisions and explanations acceptable.

Please note that the referenced pages and lines pertain to the revised manuscript in which changed have been tracked.

1. Editor: “Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.”

Response:

The reference list has been reviewed and is complete and correct. There are no references to retracted articles.

We have updated reference #1 to include the most recent UHNCR Global Trends Report:

UNHCR. Global Trends Report: Forced Displacement in 2021: The UN Refugee Agency; 2022 [cited 2022]. Available from: https://www.unhcr.org/62a9d1494/global-trends-report-2021.

We have added 7 new recent references (Reference numbers 5, 27, 28, 42, 43, 47, 48 in the revised manuscript) to update the background information and discussion section given the time that has passed since the last submission

5. UNHCR. Shelter: The UN Refugee Agency; 2022 [Available from: https://www.unhcr.org/shelter.html.

27. Ahmed RH, Yussuf AA, Ali AA, Iyow SN, Abdulahi M, Mohamed LM, et al. Anemia among pregnant women in internally displaced camps in Mogadishu, Somalia: a cross-sectional study on prevalence, severity and associated risk factors. BMC Pregnancy Childbirth. 2021;21(1):832.

28. Engidaw MT, Wassie MM, Teferra AS. Anemia and associated factors among adolescent girls living in Aw-Barre refugee camp, Somali regional state, Southeast Ethiopia. PLoS One. 2018;13(10):e0205381.

42. Khuri J, Wang Y, Holden K, Fly AD, Mbogori T, Mueller S, et al. Dietary Intake and Nutritional Status among Refugees in Host Countries: A Systematic Review. Adv Nutr. 2022;13(5):1846-65.

43. UNHCR. World Food Programme: The UN Refugee Agency; 2022 [Available from: https://www.unhcr.org/world-food-programme-49eed2ba6.html.

47. Government of Canada. #WelcomeAfghans: Key figures: Immigration, Refugees and Citizenship Canada; 2022 [Available from: https://www.canada.ca/en/immigration-refugees-citizenship/services/refugees/afghanistan/key-figures.html.

48. Government of Canada. Canada-Ukraine Authorization for Emergency Travel: Immigration, Refugees and Citizenship Canada; 2022. Available from: https://www.canada.ca/en/immigration-refugees-citizenship/news/2022/03/canada-ukraine-authorization-for-emergency-travel.html.

2. Reviewer #1: Important research work. I had reviewed a revision. Authors did a good job of incorporating the required changes.

Response:

Thank you.

3. Reviewer #2: “…The study displays major issues with argument flow in the conclusion as well as not considering certain confounding variables. The study mentions that culture is a significant factor in disease prevalence among different ethnic groups of refugees. However, the study does not consider culture during their data analysis and does not account for biases towards certain ethnic cultures over others when investigating the impact of refugee camps. An attempt to consider culture is made on lines 184-193 but while stating the proportion of cultures is a good start, these proportions are not accounted for data analysis…”

Response:

The second paragraph of the “Statistical Analysis” portion of the “Methods” section, describes our clustering analysis that would partially address the reviewer’s concerns. (Lines: 155-163). In this analysis we found negligible clustering by UN global region of origin for any of the outcomes of interest which suggests that the associations of interest were not significantly different across global regions.:

• Page 17, Line 363-366 further addresses these concerns: “While our study is amongst the largest Canadian refugee cohort studies conducted to-date and comprised a heterogeneous global refugee cohort from 47 different countries, it is underpowered to assess country-specific variations which may factor into the lack of significant regional or sub-regional variation in our outcomes. ”

• Line 335-350 also addresses cultures differences in the literature

4. Reviewer #2: “…Another major issue is related to the conclusion of whether refugee camps play a role in ID, anemia, and IDA prevalence. The study concludes that it does not but does not offer any reasons as to why this may be the case. This lack of support makes the conclusion lose validity…”

Response:

Thank you for pointing out our lack of clarity. This is important given our a priori motivation for this study was to investigate the association of refugee camp exposure with differences in anemia and iron deficiency outcomes among newly arrived refugees to Canada. The third paragraph of our discussion explored our null result, however, it is evident this exploration was not featured prominently nor with enough clarity. As such, we have explore our null result in more depth in paragraphs 3 and 4 of our discussion section. We have highlighted key changes as follows:

• Line 313-333: “To our knowledge, this is the first study to investigate the association of nutritional and health status with pre-migration refugee camp exposure among global refugees, from 47 different countries, resettled to a high-income country. Overall, we found no differences in the prevalence of ID, anemia, and IDA among refugees by refugee camp exposure. Our findings suggest that refugees in non-camp settings (often in urban settings) may experience similar nutritional deficiencies as well as barriers accessing food and nutritional supports as camp-dwelling refugees. A recent systematic review also showed that nutritional deficiencies are a significant problem among non-camp dwelling refugees. (42) A number of factors may be contributing to this problem. For example, non-camp refugees may lack access to supports from the World Food Programme(43) and other international aid organizations that traditionally support refugees in camp settings. Further, the majority of displaced persons are relocated to lower income countries, (1, 42) which likely have limited resources to offer to urban-dwelling refugees. Our findings appear to contradict the purported health and economic benefits of non-camp dwelling for refugees cited by the UNHCR such as greater freedom of movement and access to employment, given that nutritional deficiencies and food access barriers are most often related to poverty.(4)

• Line 341-350 “… These observed differences may be due to the geographic and cultural variability between different refugee camps, as well as significant differences in their availability of nutrition supports and medical services. Unlike previous studies that have been limited to specific global sub-regions and individual ethnocultural populations, our study investigated a global cohort of refugees across 47 countries of origin. We found negligible clustering by UN global region of origin for ID, anemia, and IDA, suggesting that the associations of interest were not significantly different across global regions. Together our findings suggest that ID, often related to food insecurity, is highly prevalent in pre-menopausal refugee women irrespective of pre-migration living situation or global origin.”

5. Reviewer #2: Furthermore, the study uses its conclusions to further explain society consequences of the refugees in lines 303-305 but this extension does not seem appropriate before validating the conclusions of this study.

Response:

We have revised our discussion section and conclusions as recommended to better interpret our study findings in the context of our a priori hypothesis. We then clarify our considerations around the potential implications of our study findings to the 98% of refugees who are not resettled to high income countries such as Canada and thus not able to undergo similar, laboratory-based health characterizations. We revised our manuscript as follows:

• Line 313-333: “To our knowledge, this is the first study to investigate the association of nutritional and health status with pre-migration refugee camp exposure among global refugees, from 47 different countries, resettled to a high-income country. Overall, we found no differences in the prevalence of ID, anemia, and IDA among refugees by refugee camp exposure. Our findings suggest that refugees in non-camp settings (often in urban settings) may experience similar nutritional deficiencies as well as barriers accessing food and nutritional supports as camp-dwelling refugees. A recent systematic review also showed that nutritional deficiencies are a significant problem among non-camp dwelling refugees. (42) A number of factors may be contributing to this problem. For example, non-camp refugees may lack access to supports from the World Food Programme(43) and other international aid organizations that traditionally support refugees in camp settings. Further, the majority of displaced persons are relocated to lower income countries, (1, 42) which likely have limited resources to offer to urban-dwelling refugees. Our findings appear to contradict the purported health and economic benefits of non-camp dwelling for refugees cited by the UNHCR such as greater freedom of movement and access to employment, given that nutritional deficiencies and food access barriers are most often related to poverty.(4)

• Line 398-406: Globally, less than 2% of refugees are resettled in high income countries such as Canada; however, studies among multinational cohorts of recently resettled refugees can improve understanding of health conditions faced by refugees regionally and universally. (50) Future studies of ID and anemia among global refugees would help to elucidate if regional and cultural differences exist, and if their prevalence varies across different nutritional and medical assistance models between refugee camps. Improved understanding of nutritional deficiencies in refugee populations may inform treatment and prevention programs, such as targeted iron supplementation programs for pre-menopausal refugee women and adolescent girls.

6. Reviewer #2: The limitations section of the study provides number limitations but without explanation. Explanations are important because it allows the reader to understand how the limitations may have impacted the data collection and data processing.

Response:

Thank you for pointing out our lack of clarity. We were limited by word count in our initial submission but have revised our limitations paragraph and elaborated on each point to explain how each limitation pertains to our study results and possibly impacts on conclusions. Our revisions are as follows:

• Line 358-379: Our study has limitations that warrant consideration. As our study was conducted at a single site, it may not be representative of refugee populations in other host-regions. Further, our study enrolment ended prior to the influx of approximately 41,000 Syrian refugees to Canada in 2015-2016, and more recent Afghan and Ukrainian refugees(46, 47), thus, it may not represent the current global refugee population. While our study is amongst the largest Canadian refugee cohort studies conducted to-date and comprised a heterogeneous global refugee cohort from 47 different countries, it is underpowered to assess country-specific variations which may factor into the lack of significant regional or sub-regional variation in our outcomes. Moreover, we only identified two cases of severe anemia in our study and may underestimate the prevalence of severe anemia cases that may present to acute care settings. This may be due to a selection bias given that our study relied on outpatient laboratory tests. Alternatively, selection pressures during the refugee migration process may select against individuals with severe anemia who may succumb to its complications or be unable to travel.(48) In addition, because our study was restricted to adult refugees and claimants, post-menarche adolescent girls, who likely also experience high prevalence of ID, anemia, and IDA were not included, thus potentially underestimating their prevalence. Finally, in our cohort, 19% of refugees had resided in a refugee camp prior to arrival in Canada, lower than current global trends, where 24% of global refugees reside in camps,(3) suggesting camp-exposure may be underrepresented in our cohort.

7. Reviewer #2: “There were also some formatting issues in the report for data tables. Table 1 was difficult to read in some areas due to units not being clear for certain rows such as the numbers in brackets corresponding to the row “Months in Canada Prior to Blood.”

Response:

Thank you for pointing this out. We have now corrected the formatting of Table 1 so that the alignment is improved and it is easier to follow. Our revised Table 1 can be found on p.10-11 line 203-207 in the manuscript and below:

Table 1. Patient characteristics by sex and refugee camp exposure (N = 1032).

Variable Female N = 534 Male N = 498

Refugee Camp +

N = 94 Refugee Camp -

N = 440 p-value* Refugee Camp +

N = 99 Refugee Camp -

N = 399 p-value*

Age (years) – Median

[IQR] 30.3

[23.6-38.3] 31.4

[25.5-40.0] 0.28 32.0

[25.5-42.4] 32.7

[26.5-41.1] 0.92

Months in Canada Prior to Blood Tests – Median

[IQR]

1.1

[0.7-1.9] 1.4

[0.8-2.5] 0.08 1.2

[0.8-2.1] 1.3

[0.7-2.6] 0.69

UN Global Region – N (%)

Africa 63 (67.0) 206 (46.8) < 0.01 69 (69.7) 204 (51.1) < 0.01

Americas 0 (0) 17 (3.9) 0 (0) 5 (1.3)

Asia 31 (33) 210 (47.7) 30 (30.3) 190 (47.6)

Europe 0 (0) 7 (1.6) 0 (0) 0 (0)

Number of Children –

Median

[IQR] 1

[0-4] 2

[0-3] 0.43 1

[0-2] 1

[0-2] 0.86

Pregnancy^ – N (%)

Yes 6 (6.4) 48 (10.9) 0.19 N/A

No 88 (93.6) 392 (89.1)

Refugee Category#

GAR 71 (75.5) 204 (46.4) < 0.01 65 (65.7) 188 (47.1) < 0.01

PSR 23 (24.5) 191 (43.4) 34 (34.3) 180 (45.1)

Claimant 0 (0) 45 (10.2) 0 (0) 31 (7.8)

English Language proficiency at intake– N (%)

None 61 (64.9) 214 (48.6) 38 (38.4) 129 (32.3)

Limited 11 (11.7) 73 (16.6) 20 (20.2) 86 (21.6)

Good 22 (23.4) 153 (34.8) 0.02 41 (41.4) 184 (46.1) 0.52

*p-values calculated using a Wilcoxon rank sum test for comparison of medians and chi-square or Fisher’s exact tests for comparison of frequencies. #GAR refer to Government assisted refugees, PSR refers to privately sponsored refugees, and Claimant refers to refugee claimants or asylum seeker. ^Pregnant refers to active pregnancy at the time of laboratory investigations. N/A refers to not applicable.

8. Reviewer 2: “Another issue is with result presentation. A pie chart is oftentimes not suitable to display proportions exceeding two variables because the proportions become difficult to compare. Therefore, I would recommend changing the graph type to a more suitable graph where the comparisons between variables are more obvious, such as a bar graph.”

Response:

Thank you for pointing this out. We have now changed our pie chart (Figure 4) to a bar graph as follows:

9. Reviewer #2: Lastly, there are grammatical issues in the report. An example is the limitations paragraph which starts with a four-word topic sentence and does not adequately explain what the paragraph will be about. Furthermore, there is no flow in this paragraph as each idea is brought forward without explanation and separated by periods.

Response:

Thank you for pointing out our lack of clarity. We have extensively revised our limitation paragraph to improve its coherence and logical flow.

10. Reviewer #2: There are examples of awkward syntax such as the sentence on lines 139-141 having no verb and therefore, not being a complete sentence.

Response:

We have revised the manuscript throughout to improve grammar, flow, and coherence. Our grammatical revisions are highlighted in the manuscript with tracked changes.

In addition, we grammatically revised the paragraph noted above on lines 139-141 (lines 122-127 in revised manuscript). Our revisions are as follows:

• p.6 122-127: “We defined mild, moderate, and severe anemia among non-pregnant women as a hemoglobin concentration of: 110-119g/L, 80-109g/L, and <80g/L, respectively, and among pregnant women as 100-109g/L, 70-99g/L, and <70g/L, respectively.”

We thank the editor and reviwers for the opportunity to revise our manuscript and hope that you will find our revisions satisfactory.

Sincerely,

Marta Davidson MD, PhD, FRCPC

Hematologist

Princess Margaret Hospital

Toronto, Ontario

Attachment

Submitted filename: Response to reviewers - October 15, 2022.docx

Decision Letter 2

Mabel Aoun

28 Nov 2022

Iron deficiency, Anemia and Association with Refugee Camp Exposure Among Recently Resettled Refugees:  a Canadian retrospective cohort study

PONE-D-21-12986R2

Dear Dr. Davidson,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mabel Aoun, MD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mabel Aoun

6 Dec 2022

PONE-D-21-12986R2

Iron deficiency, anemia and association with refugee camp exposure among recently resettled refugees: a Canadian retrospective cohort study

Dear Dr. Davidson:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mabel Aoun

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Sensitivity analysis.

    For sensitivity analysis, ID was defined as a serum transferrin saturation (tsat) ≤ 0.16 and IDA was defined as the presence of anemia as defined by WHO thresholds in combination with a tsat ≤ 0.16. Multi-variable logistic regression was used to estimate the odds of ID, anemia, and IDA in female refugees after adjusting for refugee camp exposure, age, global region of origin (defined by UN global regions), pregnancy status and number of children.

    (TIF)

    S1 Table. Sensitivity analysis; primary outcomes by sex and refugee camp exposure using serum transferrin saturation (tsat) (N = 1032).

    (DOCX)

    S2 Table. Sensitivity analysis: Unadjusted outcomes among female refugees using transferring saturation (tsat) (N = 534).

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers - Sept 17.21.docx

    Attachment

    Submitted filename: Response to reviewers - October 15, 2022.docx

    Data Availability Statement

    Data cannot be shared publicly because permission is restricted by the data custodian and current active research agreement. For further inquiries regarding the data sharing restrictions please contact the data custodian’s (the Mosaic Primary Care Network) privacy officer Dr. Valerie Fleisch (privacy@mosaicpcn.ca).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES